InvestorsHub Logo
Followers 8
Posts 478
Boards Moderated 0
Alias Born 03/12/2016

Re: pcguy post# 160468

Monday, 07/30/2018 7:46:36 AM

Monday, July 30, 2018 7:46:36 AM

Post# of 463151

Why not wait for P2b/P3 to complete? Then you would have more conclusive scientific information to support your case. Should only be about 2 years away..


Good morning PCguy

"Why not wait?" From the Alzhimers Association website "Every 65 SECONDS SOMEONE IN THE UNITED STATES DEVELOPS THE DISEASE."
This computes to 485,189 people per year in the US alone or approximately 1,000,000 people in two years.

I live in a retirement community and observe those affected progress from having normal functioning lives to the "death chamber" of Memory Care. Also, I happen to be a prime candidate having had chronic inflammation for many years and would take A2-73 now if it could become available through the "Right to Try" law. The anecdotal reports and videos from the Australian trial and extensions and the safety for three years of dosing are very convincing to me.

In my past business experience, I often ran into statements such as "We have always done it this way" and my answer was "Let's try this way to see if it can be improved or get better results" which often was the case. Granted it would be much easier to get results with information from P2 and P2/3 trials available. But if 500 people sent emails or letters to 5 people or organizations or letters to editors we would possibly raise the awareness of the need for quicker action.
"If Not Now Then When?"


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News